Work

Health economic considerations for pharmacogenomic services in the United Kingdom: The Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics

Year: 2025

Type: article

Source: British Journal of Clinical Pharmacology

DOI: 10.1002/bcp.70412

Authors: Dyfrig A. Hughes, Henry Fong, Grace Hampson, Catrin O. Plumpton, Chris Sampson

Institutions: Bangor University, Office Of Health Economics

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,780

Funders: Queen Mary University of London, British Pharmacological Society, Bangor University, Center of Excellence in Regulatory Science and Innovation, Innovate UK

Award: G3723443717

OpenAlex ID: W4417176003

FWCI: 1.727

Cites: 7

Cited by: 2

Related to: